Inventor

Henricus Jacobus Maria Gijsen

Inventor

Breda, NL

Overview

38→

Patents

2003–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 38 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds40%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%

A61KPreparations for medical, dental or toiletry purposes21%

Y02PClimate change mitigation technologies in the production or processing of goods2%

PatentTitleYear

11,053,248[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors2021 10,947,239[1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound2021 10,947,242[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors2021 10,653,673Substituted imidazoles as N-type calcium channel blockers2020 10,562,897Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators2020 10,246,454Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators2019 10,112,943Substituted imidazoles as gamma secretase modulators2018 10,106,5242,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase2018 9,974,775Substituted imidazoles as N-type calcium channel blockers2018 9,840,507'5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)'2017 9,834,5594-Amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2H)-one derivatives as inhibitors of beta-secretase (BACE)2017 9,828,3505,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)2017 9,751,886'4-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)'2017 9,580,433'4-amino-6-phenyl-5,6-dihydroimidazo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)'2017 9,453,002'Substituted imidazoles as N-type calcium channel blockers'2016 9,346,811'6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (BACE)'2016 9,284,303'Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group'2016 9,181,245'Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer\'s disease'2015 9,145,399'Substituted bicyclic triazole derivatives as gamma secretase modulators'2015 9,115,143'Substituted indole derivatives as gamma secretase modulators'2015 9,079,886'Substituted triazole derivatives as gamma secretase modulators'2015 8,946,266'Substituted triazole and imidazole derivatives as gamma secretase modulators'2015 8,946,426'Substituted bicyclic heterocyclic compounds as gamma secretase modulators'2015 8,835,482'Substituted indazole and aza-indazole derivatives as gamma secretase modulators'2014 8,772,504'Substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators'2014 8,614,201'Heterocyclic amides as modulators of TRPA1'2013 8,546,440'Substituted bicyclic imidazole derivatives as gamma secretase modulators'2013 8,524,757'Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group'2013 8,461,145'Dibenzoazepine and dibenzooxazepine TRPA1 agonists'2013 8,334,304'Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists'2012 8,193,369'Benzimidazole cannabinoid agonists'2012 7,732,464'Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists'2010 7,652,040'Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists'2010 7,638,535'4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists'2009 7,635,706'5HT4-antagonistic 4-(aminomethyl)-piperidine benzamides'2009 7,498,347'Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4 antagonists'2009 7,205,410'4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders'2007 6,544,997'4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2021Patents assigned to JANSSEN PHARMACEUTICA NV (29)· patent assignee history

2003–2021Based in Breda, NL· patent location history

2012–2017Patents assigned to GIJSEN HENRICUS JACOBUS MARIA (15)· patent assignee history

2013–2015Patents assigned to JANSSEN PHARMACEUTICALS INC (9)· patent assignee history

2013–2015Patents assigned to BERTHELOT DIDIER JEAN-CLAUDE (7)· patent assignee history

2013–2018Based in Beerse, BE· patent location history

2014–2015Patents assigned to CELLZOME LTD (8)· patent assignee history

2021Based in AH Breda, NL· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
JANSSEN PHARMACEUTICA NV	29	2003–2021
GIJSEN HENRICUS JACOBUS MARIAself	15	2012–2017
JANSSEN PHARMACEUTICALS INC	9	2013–2015
CELLZOME LTD	8	2014–2015
BERTHELOT DIDIER JEAN-CLAUDE	7	2013–2015

Locations

Location	Patents	Span
Breda, NL	31	2003–2021
Beerse, BE	6	2013–2018
AH Breda, NL	1	2021